$ABPO 4 SEC Filings

Filed On	Filing
07 Aug 2025	Form 4: Lee Soo Young, Director Granted 60,600 Stock option (right to buy)
04 Aug 2025	Form 4: Suk Jin Wook (Miles), Director Bought 72,035 shares ($20.2K)
29 Jul 2025	Form 4: Eisenberg Anthony D., Director Granted 60,600 Stock option (right to buy)
29 Jul 2025	Form 4: Suk Jin Wook (Miles), Director Received 500,000 shares as a grant or award
19 May 2025	Form 4: Suk Jin Wook (Miles), Director Bought 16,200 shares ($4.21K)
01 May 2025	Form 4: Suk Jin Wook (Miles), Director Bought 4,325 shares ($1.08K)
25 Apr 2025	Form 4: Suk Jin Wook (Miles), Director Bought 7,460 shares ($2.09K) · Bought 26,542 shares ($9.02K)
25 Nov 2024	Form 4: Chan Ian, Director Received 8,652,800 shares as a grant or award · Granted 2,929,200 Stock option (right to buy)
15 Nov 2024	Form 4: Suk Jin Wook (Miles), Director Received 91,900 shares as a grant or award
15 Nov 2024	Form 4: Markelewicz Robert J. Jr., Chief Medical Officer Granted 760,000 Stock option (right to buy)
08 Nov 2023	Form 4: Kahlon Iqbaljit, Director Disposed of 50,000 shares (Other Transaction)
08 Nov 2023	Form 4: Ahmad Shahraab, Director and 1 other Acquired 50,000 shares (Other Transaction) · Disposed of 50,000 shares (Other Transaction)
19 Apr 2023	Form 4: Lord Joanna, Director Received 50,000 shares by exercise or conversion
19 Apr 2023	Form 4: Kahlon Iqbaljit, Director Received 50,000 shares by exercise or conversion
19 Apr 2023	Form 4: Ahmad Shahraab, Director and 1 other Received 7,199,999 shares by exercise or conversion
19 Apr 2023	Form 4: Schiano Dominick, Director Received 50,000 shares by exercise or conversion
19 Apr 2023	Form 4: Stanwood Darren, Director Received 50,000 shares by exercise or conversion
19 Apr 2023	Form 4: Dove Bryan, Director Received 50,000 shares by exercise or conversion
19 Jan 2022	Form 4: Ahmad Shahraab, Director and 1 other Disposed of 53,750 Series B Common Stock, par value $0.0001 per share (Other Transaction)

Comments